Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...
May 25, 2017 11:06 am UTC| Business
FREMONT, Calif., May 25, 2017 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that Gayn Erickson, President and CEO, will participate at the 14th...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 11:06 am UTC| Business
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc...